Skip to content
Metri Bio's CEO, Ashley Abel, selected for
Forbes 30 Under 30
Metri Bio Raises $5M Pre-Seed
to Develop Endometriosis Therapeutics
About
Team
Careers
About
Team
Careers
Contact us
Metri Bio is working to radically improve the lives of people suffering from diseases that impact the endometrium.
Please reach out to Ashley with any inquiries.
Ashley Abel, PhD
CEO & Co-Founder
ashley@metri.bio